Blood-Brain Barrier: From Physiology to Disease and Back.
暂无分享,去创建一个
[1] G. Bu,et al. Apolipoprotein E, Receptors, and Modulation of Alzheimer’s Disease , 2018, Biological Psychiatry.
[2] Koji Ando,et al. A molecular atlas of cell types and zonation in the brain vasculature , 2018, Nature.
[3] Madelaine Daianu,et al. Pericyte degeneration causes white matter dysfunction in the mouse central nervous system , 2018, Nature Medicine.
[4] Berislav V. Zlokovic,et al. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.
[5] S. Love,et al. Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] Soo-Hong Lee,et al. Matrix Metalloproteinase-8 Inhibition Prevents Disruption of Blood–Spinal Cord Barrier and Attenuates Inflammation in Rat Model of Spinal Cord Injury , 2017, Molecular Neurobiology.
[7] B. Zlokovic,et al. Alzheimer’s disease: A matter of blood–brain barrier dysfunction? , 2017, The Journal of experimental medicine.
[8] A. Becker,et al. Subcellular reorganization and altered phosphorylation of the astrocytic gap junction protein connexin43 in human and experimental temporal lobe epilepsy , 2017, Glia.
[9] K. Blennow,et al. CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients , 2017, Neurobiology of Aging.
[10] K. Zaghloul,et al. Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI , 2017, eLife.
[11] A. Fagan,et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy , 2017, Nature.
[12] C. Iadecola. The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease , 2017, Neuron.
[13] P. Couraud,et al. Regulation of Tight-Junction Integrity by Insulin in an In Vitro Model of Human Blood-Brain Barrier. , 2017, Journal of pharmaceutical sciences.
[14] Nick C Fox,et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.
[15] J. Nathans,et al. Reck and Gpr124 Are Essential Receptor Cofactors for Wnt7a/Wnt7b-Specific Signaling in Mammalian CNS Angiogenesis and Blood-Brain Barrier Regulation , 2017, Neuron.
[16] Anders M. Dale,et al. Interstitial solute transport in 3D reconstructed neuropil occurs by diffusion rather than bulk flow , 2017, Proceedings of the National Academy of Sciences.
[17] D. Arnold,et al. MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis , 2017, Neurology.
[18] M. van Buchem,et al. Subtle blood‐brain barrier leakage rate and spatial extent: Considerations for dynamic contrast‐enhanced MRI , 2017, Medical physics.
[19] Xiaoming Yao,et al. Test of the 'glymphatic' hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma , 2017, eLife.
[20] Antonio Carlos Pedroso de Lima,et al. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient , 2017, Stem Cell Reviews and Reports.
[21] Shengdi Chen,et al. Endothelial progenitor cells transplantation attenuated blood-brain barrier damage after ischemia in diabetic mice via HIF-1α , 2017, Stem Cell Research & Therapy.
[22] K. Hynynen,et al. Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound , 2017, Neuropharmacology.
[23] C. Jack,et al. Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults: Mayo Clinic Study of Aging , 2017, JAMA neurology.
[24] Lubo Zhang,et al. MicroRNA-210 Suppresses Junction Proteins and Disrupts Blood-Brain Barrier Integrity in Neonatal Rat Hypoxic-Ischemic Brain Injury , 2017, International journal of molecular sciences.
[25] B. Barres,et al. Reactive Astrocytes: Production, Function, and Therapeutic Potential. , 2017, Immunity.
[26] K. Hao,et al. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease , 2017, Nature Neuroscience.
[27] A. Markham,et al. Cerliponase Alfa: First Global Approval , 2017, Drugs.
[28] Sean P. Palecek,et al. Modeling Psychomotor Retardation using iPSCs from MCT8-Deficient Patients Indicates a Prominent Role for the Blood-Brain Barrier. , 2017, Cell stem cell.
[29] J. Thomson,et al. Specification and Diversification of Pericytes and Smooth Muscle Cells from Mesenchymoangioblasts , 2017, Cell reports.
[30] V. Gradinaru,et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems , 2017, Nature Neuroscience.
[31] D. Ekstein,et al. Breaking Bad: the Structure and Function of the Blood-Brain Barrier in Epilepsy , 2017, The AAPS Journal.
[32] D. Vivien,et al. Prediction of disease activity in models of multiple sclerosis by molecular magnetic resonance imaging of P-selectin , 2017, Proceedings of the National Academy of Sciences.
[33] B. Zlokovic,et al. Remote control of BBB: A tale of exosomes and microRNA , 2017, Cell Research.
[34] Axel Montagne,et al. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease , 2017, Nature Reviews Neuroscience.
[35] H. Augustin,et al. Plastic roles of pericytes in the blood–retinal barrier , 2017, Nature Communications.
[36] S. Strickland,et al. Depletion of coagulation factor XII ameliorates brain pathology and cognitive impairment in Alzheimer disease mice. , 2017, Blood.
[37] D. Ginty,et al. Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis , 2017, Neuron.
[38] D. Dunstan,et al. Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health , 2017, Alzheimer's & dementia.
[39] J. Nicolazzo,et al. Neurovascular Alterations in Alzheimer’s Disease: Transporter Expression Profiles and CNS Drug Access , 2017, The AAPS Journal.
[40] B. Zlokovic,et al. Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-β signaling , 2017, PloS one.
[41] Ji-wen Bu,et al. Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity , 2017, Cell Research.
[42] M. Pogson,et al. Reprogramming MHC specificity by CRISPR-Cas9-assisted cassette exchange , 2017, Scientific Reports.
[43] N. Mercuri,et al. Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients. , 2017, CNS & neurological disorders drug targets.
[44] M. Haaparanta-Solin,et al. HPLC and TLC methods for analysis of [18F]FDG and its metabolites from biological samples. , 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[45] Scott B. Thompson,et al. Ena/VASP proteins regulate activated T-cell trafficking by promoting diapedesis during transendothelial migration , 2017, Proceedings of the National Academy of Sciences.
[46] Nathan R. Tykocki,et al. Capillary K+-sensing initiates retrograde hyperpolarization to locally increase cerebral blood flow , 2017, Nature Neuroscience.
[47] W. Pardridge,et al. Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody-Iduronidase Fusion Protein. , 2017, Molecular pharmaceutics.
[48] Howard Y. Chang,et al. Gpr124 is essential for blood–brain barrier integrity in central nervous system disease , 2017, Nature Medicine.
[49] K. Blennow,et al. Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype , 2017, Neurobiology of Aging.
[50] F. Shang,et al. Proteotoxic Stress Desensitizes TGF-beta Signaling Through Receptor Downregulation in Retinal Pigment Epithelial Cells , 2017, Current molecular medicine.
[51] L. Calderón-Garcidueñas,et al. Living close to heavy traffic roads, air pollution, and dementia , 2017, The Lancet.
[52] E. Amico,et al. Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington’s disease transgenic R6/2 (160 CAG) mice , 2017, Scientific Reports.
[53] J. Hardy,et al. Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) players , 2017, Acta Neuropathologica.
[54] Akiyoshi Uemura,et al. Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown. , 2017, JCI insight.
[55] E. Dolgin. Spinal muscular atrophy approval boosts antisense drugs , 2017, Nature Biotechnology.
[56] R. Klein,et al. Infectious immunity in the central nervous system and brain function , 2017, Nature Immunology.
[57] B. Engelhardt,et al. The movers and shapers in immune privilege of the CNS , 2017, Nature Immunology.
[58] Marco Prinz,et al. The role of peripheral immune cells in the CNS in steady state and disease , 2017, Nature Neuroscience.
[59] A. Al-Chalabi,et al. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management , 2017, Nature Reviews Neurology.
[60] Ann-Christin Ostwaldt,et al. DCE-MRI blood–brain barrier assessment in acute ischemic stroke , 2017, Neurology.
[61] D. Boas,et al. Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain , 2017, Nature Neuroscience.
[62] Zhen Gu,et al. Leveraging Physiology for Precision Drug Delivery , 2017 .
[63] M. Frosch,et al. APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review. , 2017, Journal of Alzheimer's disease : JAD.
[64] L. Calderón-Garcidueñas,et al. Combustion-Derived Nanoparticles in Key Brain Target Cells and Organelles in Young Urbanites: Culprit Hidden in Plain Sight in Alzheimer's Disease Development. , 2017, Journal of Alzheimer's disease : JAD.
[65] Neekita Jikaria,et al. Disrupting the blood–brain barrier by focused ultrasound induces sterile inflammation , 2016, Proceedings of the National Academy of Sciences.
[66] Vartan Kurtcuoglu,et al. Glymphatic solute transport does not require bulk flow , 2016, Scientific Reports.
[67] Yigong Shi,et al. Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase , 2016, Proceedings of the National Academy of Sciences.
[68] Sudha Seshadri,et al. Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association , 2016, Hypertension.
[69] Alan S. Verkman,et al. Spatial model of convective solute transport in brain extracellular space does not support a “glymphatic” mechanism , 2016, The Journal of general physiology.
[70] H. Wiendl,et al. Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier , 2016, Science Translational Medicine.
[71] Liqun He,et al. Analysis of the brain mural cell transcriptome , 2016, Scientific Reports.
[72] V. Pialoux,et al. Exercise Does Not Protect against Peripheral and Central Effects of a High Cholesterol Diet Given Ad libitum in Old ApoE−/− Mice , 2016, Front. Physiol..
[73] R. Barker,et al. Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease , 2016, Movement disorders : official journal of the Movement Disorder Society.
[74] V. Ramakrishnan,et al. Association between MDR1 gene polymorphisms and Parkinson's disease in Asian and Caucasian populations: a meta-analysis , 2016, Journal of the Neurological Sciences.
[75] E. Newman,et al. Glial Cell Calcium Signaling Mediates Capillary Regulation of Blood Flow in the Retina , 2016, The Journal of Neuroscience.
[76] Walter H. Backes,et al. Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging , 2016, Neurobiology of Aging.
[77] Britta Engelhardt,et al. Vascular, glial, and lymphatic immune gateways of the central nervous system , 2016, Acta Neuropathologica.
[78] Bin Zhou,et al. Endothelial cells are progenitors of cardiac pericytes and vascular smooth muscle cells , 2016, Nature Communications.
[79] Raquel Ferreira,et al. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[80] Y. Imaizumi,et al. Hypoxic stress up-regulates Kir2.1 expression and facilitates cell proliferation in brain capillary endothelial cells. , 2016, Biochemical and biophysical research communications.
[81] C. Giampietro,et al. Angiomotin like-1 is a novel component of the N-cadherin complex affecting endothelial/pericyte interaction in normal and tumor angiogenesis , 2016, Scientific Reports.
[82] A. Gerrish,et al. Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer’s disease , 2016, BMC Neuroscience.
[83] I. Zerr,et al. Cerebral microbleeds in early Alzheimer’s disease , 2016, Journal of Neurology.
[84] R. Irwin,et al. ALLOPREGNANOLONE PROMOTES CHOLESTEROL AND AMYLOID-BETA CLEARANCE MECHANISMS: ASSESSMENT OF A REGENERATIVE THERAPEUTIC FOR ALZHEIMER’S DISEASE , 2016, Alzheimer's & Dementia.
[85] Norbert Schuff,et al. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.
[86] David A. Bennett,et al. Relation of Cerebral Vessel Disease to Alzheimer’s Disease Dementia and Cognitive Function in Older Persons: A Cross-sectional Study , 2016, The Lancet Neurology.
[87] Kristofer J. Thurecht,et al. Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date , 2016, Pharmaceutical Research.
[88] B. Zlokovic,et al. Pericytes of the neurovascular unit: key functions and signaling pathways , 2016, Nature Neuroscience.
[89] Imre Mäger,et al. Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers , 2016, Nature Reviews Neurology.
[90] Walter H Backes,et al. Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease. , 2016, Radiology.
[91] S. Barger,et al. A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid β -Peptide from the Brain. , 2016, Current Alzheimer research.
[92] J. Meaney,et al. Blood–Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy , 2016, Journal of neuropathology and experimental neurology.
[93] Vishnu B. Sridhar,et al. Cell type specificity of neurovascular coupling in cerebral cortex , 2016, eLife.
[94] Wutian Wu,et al. Caveolin-1 Is Critical for Lymphocyte Trafficking into Central Nervous System during Experimental Autoimmune Encephalomyelitis , 2016, The Journal of Neuroscience.
[95] B. Zlokovic,et al. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. , 2016, Biochimica et biophysica acta.
[96] C. Iadecola,et al. Adipocyte-derived factors in age-related dementia and their contribution to vascular and Alzheimer pathology. , 2016, Biochimica et biophysica acta.
[97] Axel Montagne,et al. Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood–brain barrier permeability using dynamic contrast‐enhanced MRI , 2016, Magnetic resonance in medicine.
[98] J. Zarranz,et al. Iowa APP mutation-related hereditary cerebral amyloid angiopathy (CAA): A new family from Spain , 2016, Journal of the Neurological Sciences.
[99] S. LeVine. Albumin and multiple sclerosis , 2016, BMC Neurology.
[100] C. Nicholson,et al. Erratum: Clearance systems in the brain—implications for Alzheimer diseaser , 2016 .
[101] Arthur W. Toga,et al. Brain imaging of neurovascular dysfunction in Alzheimer’s disease , 2016, Acta Neuropathologica.
[102] W. Banks,et al. From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery , 2016, Nature Reviews Drug Discovery.
[103] Jian Cheng,et al. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke , 2016, Translational Stroke Research.
[104] H. Budka,et al. Dura mater is a potential source of Aβ seeds , 2016, Acta Neuropathologica.
[105] Clotilde Théry,et al. Communication by Extracellular Vesicles: Where We Are and Where We Need to Go , 2016, Cell.
[106] M. Ihara,et al. Interaction between cerebrovascular disease and Alzheimer pathology , 2016, Current opinion in psychiatry.
[107] M. Nelson,et al. Ion channel networks in the control of cerebral blood flow , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[108] Giovanni Coppola,et al. Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database , 2016, Journal of neuropathology and experimental neurology.
[109] J. Rogers,et al. Analysis of the Putative Role of CR1 in Alzheimer’s Disease: Genetic Association, Expression and Function , 2016, PloS one.
[110] M. Neri,et al. Early Loss of Blood-Brain Barrier Integrity Precedes NOX2 Elevation in the Prefrontal Cortex of an Animal Model of Psychosis , 2016, Molecular Neurobiology.
[111] E. S. Graham,et al. TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function , 2016, Journal of Neuroinflammation.
[112] J. Pope,et al. Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain , 2016, Neuromodulation : journal of the International Neuromodulation Society.
[113] M. Schwaninger,et al. Apicobasal polarity of brain endothelial cells , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[114] T. Morgan,et al. The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice , 2016, Neurobiology of Aging.
[115] R. Keep,et al. Rapid endothelial cytoskeletal reorganization enables early blood–brain barrier disruption and long-term ischaemic reperfusion brain injury , 2016, Nature Communications.
[116] Andrew Levine,et al. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study , 2016, Neurology.
[117] Joanna M. Wardlaw,et al. Tracer kinetic modelling for DCE-MRI quantification of subtle blood–brain barrier permeability , 2016, NeuroImage.
[118] S. Minoshima,et al. Repetitive blast exposure in mice and combat veterans causes persistent cerebellar dysfunction , 2016, Science Translational Medicine.
[119] Melanie A. Huntley,et al. Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies , 2016, Neuron.
[120] C. Hammer,et al. The brain as immunoprecipitator of serum autoantibodies against N‐Methyl‐D‐aspartate receptor subunit NR1 , 2016, Annals of neurology.
[121] B. Zlokovic,et al. Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[122] C. Iadecola,et al. Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[123] Sripriya Ravindra Kumar,et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain , 2015, Nature Biotechnology.
[124] T. Bayer,et al. Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier. , 2015, The Journal of clinical investigation.
[125] Kullervo Hynynen,et al. Microbubble-Assisted Ultrasound for Drug Delivery in the Brain and Central Nervous System. , 2016, Advances in experimental medicine and biology.
[126] E. Gómez-Tortosa,et al. Novel Mutation (Gly212Val) in the PS2 Gene Associated with Early-Onset Familial Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.
[127] J. Nathans,et al. Frizzled Receptors in Development and Disease. , 2016, Current topics in developmental biology.
[128] L. Wahlund,et al. Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field. , 2016, Biomarkers in medicine.
[129] Brian J. Bacskai,et al. Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases , 2016, Cellular and Molecular Neurobiology.
[130] Y. Lyubchenko,et al. Nonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis , 2015, Proceedings of the National Academy of Sciences.
[131] P. Pasinelli,et al. Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders , 2015, Brain Research.
[132] S. Carmichael,et al. Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury. , 2015, Current opinion in neurology.
[133] N. Plesnila,et al. Pericytes are involved in the pathogenesis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy , 2015, Annals of neurology.
[134] K. Blennow,et al. Increased CSF biomarkers of angiogenesis in Parkinson disease , 2015, Neurology.
[135] Michael A. Miller. Patterning with Diffusion Barriers. , 2015, Developmental cell.
[136] Zhen Zhao,et al. Establishment and Dysfunction of the Blood-Brain Barrier , 2015, Cell.
[137] Nick C Fox,et al. Qualitative changes in human γ-secretase underlie familial Alzheimer’s disease , 2015, The Journal of experimental medicine.
[138] D. A. Bergstrom,et al. Pre-Clinical Traumatic Brain Injury Common Data Elements: Toward a Common Language Across Laboratories. , 2015, Journal of neurotrauma.
[139] M. Campbell,et al. The dynamic blood–brain barrier , 2015, The FEBS journal.
[140] D. Vestweber,et al. How leukocytes cross the vascular endothelium , 2015, Nature Reviews Immunology.
[141] B. Lacoste,et al. Control of cerebrovascular patterning by neural activity during postnatal development , 2015, Mechanisms of Development.
[142] S. R. Snodgrass,et al. A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans , 2015, Experimental Neurology.
[143] V. Hachinski. Stroke and Potentially Preventable Dementias Proclamation: Updated World Stroke Day Proclamation. , 2015, Stroke.
[144] I. Weissman,et al. Pericytes are progenitors for coronary artery smooth muscle , 2015, eLife.
[145] C. Hammer,et al. The brain as immunoprecipitator of serum autoantibodies against N‐Methyl‐D‐aspartate receptor subunit NR1 , 2015, Annals of neurology.
[146] W. Funkhouser,et al. APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction , 2015, PLoS biology.
[147] H. Park,et al. Mesenchymal stem cells stabilize the blood–brain barrier through regulation of astrocytes , 2015, Stem Cell Research & Therapy.
[148] Victoria A. Rafalski,et al. Breaking boundaries—coagulation and fibrinolysis at the neurovascular interface , 2015, Front. Cell. Neurosci..
[149] Sara G. Murray,et al. Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation , 2015, Nature Communications.
[150] R. Klein,et al. Knocking on Closed Doors: Host Interferons Dynamically Regulate Blood-Brain Barrier Function during Viral Infections of the Central Nervous System , 2015, PLoS pathogens.
[151] N. Plesnila,et al. Pericytes are involved in the pathogenesis of CADASIL , 2015 .
[152] E. Aronica,et al. Status epilepticus, blood–brain barrier disruption, inflammation, and epileptogenesis , 2015, Epilepsy & Behavior.
[153] Chiao-Chi V. Chen,et al. Aberrant astrocytes impair vascular reactivity in Huntington disease , 2015, Annals of neurology.
[154] D. Catalucci,et al. Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin , 2015, Nature Medicine.
[155] Susan T Francis,et al. Cerebrovascular and blood–brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology , 2015, Annals of neurology.
[156] Jette L. Frederiksen,et al. Permeability of the blood–brain barrier predicts conversion from optic neuritis to multiple sclerosis , 2015, Brain : a journal of neurology.
[157] M. Schwab,et al. Wiring the Vascular Network with Neural Cues: A CNS Perspective , 2015, Neuron.
[158] W. Pardridge. Blood–brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery , 2015, Expert opinion on therapeutic targets.
[159] V. Funck,et al. Contrasting effects of Na+, K+-ATPase activation on seizure activity in acute versus chronic models , 2015, Neuroscience.
[160] Baptiste Lacoste,et al. Neuronal and vascular interactions. , 2015, Annual review of neuroscience.
[161] H. Augustin,et al. Mechanisms of Vessel Pruning and Regression. , 2015, Developmental cell.
[162] Guo-Yuan Yang,et al. MicroRNA-29b is a Therapeutic Target in Cerebral Ischemia Associated with Aquaporin 4 , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[163] S. Gabriel,et al. Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome , 2015, Nature Genetics.
[164] M. Weedon,et al. A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome , 2015, Nature Genetics.
[165] S. Strickland,et al. Chronic Hypertension Leads to Neurodegeneration in the TgSwDI Mouse Model of Alzheimer’s Disease , 2015, Hypertension.
[166] Michael Detmar,et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules , 2015 .
[167] Sarah Hurst Petrosko,et al. Accelerating the Translation of Nanomaterials in Biomedicine. , 2015, ACS nano.
[168] M. Giugliano,et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.
[169] Russell E. Jacobs,et al. ROCKETSHIP: a flexible and modular software tool for the planning, processing and analysis of dynamic MRI studies , 2015, BMC Medical Imaging.
[170] Richa Gupta,et al. Exosomes as drug delivery vehicles for Parkinson's disease therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[171] J. Nathans,et al. Tip cell-specific requirement for an atypical Gpr124- and Reck-dependent Wnt/β-catenin pathway during brain angiogenesis , 2015, eLife.
[172] Paul M. Matthews,et al. Reduced cerebrovascular reactivity in young adults carrying the APOE ε4 allele , 2015, Alzheimer's & Dementia.
[173] Timothy J Keyes,et al. Structural and functional features of central nervous system lymphatics , 2015, Nature.
[174] J. Schneider,et al. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease , 2015, Alzheimer's & Dementia.
[175] J. Antel,et al. Netrin 1 regulates blood-brain barrier function and neuroinflammation. , 2015, Brain : a journal of neurology.
[176] T. Owens,et al. Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier , 2015, Annals of clinical and translational neurology.
[177] Britta Engelhardt,et al. Brain barriers: Crosstalk between complex tight junctions and adherens junctions , 2015, The Journal of cell biology.
[178] L. Case,et al. Tumor-induced loss of mural Connexin 43 gap junction activity promotes endothelial proliferation , 2015, BMC Cancer.
[179] Maiken Nedergaard,et al. The Glymphatic System: A Beginner’s Guide , 2015, Neurochemical Research.
[180] J. Griffin,et al. Activated protein C: biased for translation. , 2015, Blood.
[181] J. Schneider,et al. Central role for PICALM in amyloid–β blood–brain barrier transcytosis and clearance , 2015, Nature Neuroscience.
[182] Albert C. Huang,et al. Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier , 2015, Science Translational Medicine.
[183] G. Bu,et al. Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway* , 2015, The Journal of Biological Chemistry.
[184] B. Zlokovic,et al. Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[185] B. Engelhardt,et al. Cell surface levels of endothelial ICAM‐1 influence the transcellular or paracellular T‐cell diapedesis across the blood–brain barrier , 2015, European journal of immunology.
[186] Jesse D. Sengillo,et al. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration , 2015, Nature Neuroscience.
[187] L. Wahlund,et al. Cerebral Microbleeds: Different Prevalence, Topography, and Risk Factors Depending on Dementia Diagnosis—The Karolinska Imaging Dementia Study , 2015, American Journal of Neuroradiology.
[188] M. Schwartz,et al. ZO-1 controls endothelial adherens junctions, cell–cell tension, angiogenesis, and barrier formation , 2015, The Journal of cell biology.
[189] Christina Lin,et al. LSR/angulin-1 is a tricellular tight junction protein involved in blood–brain barrier formation , 2015, The Journal of cell biology.
[190] J. Hoh,et al. Loss of HtrA1-induced attenuation of TGF-β signaling in fibroblasts might not be the main mechanism of CARASIL pathogenesis , 2015, Proceedings of the National Academy of Sciences.
[191] J. Woulfe,et al. Striatal Blood–Brain Barrier Permeability in Parkinson'S Disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[192] M. Cohen-Salmon,et al. Immune Quiescence of the Brain Is Set by Astroglial Connexin 43 , 2015, The Journal of Neuroscience.
[193] D. Vestweber,et al. Integrin β1 controls VE-cadherin localization and blood vessel stability , 2015, Nature Communications.
[194] S. Linnarsson,et al. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq , 2015, Science.
[195] S. Sakoda,et al. Microvascular disturbance with decreased pericyte coverage is prominent in the ventral horn of patients with amyotrophic lateral sclerosis , 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[196] S. Lule,et al. Systemically Administered Brain-Targeted Nanoparticles Transport Peptides across the Blood—Brain Barrier and Provide Neuroprotection , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[197] C. van Broeckhoven,et al. Progress in unraveling the genetic etiology of Parkinson disease in a genomic era. , 2015, Trends in genetics : TIG.
[198] D. Holtzman,et al. TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model , 2015, Cell.
[199] L. McGuinness,et al. Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease , 2015, Neurobiology of Disease.
[200] C. Larochelle,et al. Focal disturbances in the blood–brain barrier are associated with formation of neuroinflammatory lesions , 2015, Neurobiology of Disease.
[201] Farzaneh A. Sorond,et al. Apolipoprotein E, Carbon Dioxide Vasoreactivity, and Cognition in Older Adults: Effect of Hypertension , 2015, Journal of the American Geriatrics Society.
[202] U. Lendahl,et al. Notch3 Is Necessary for Blood Vessel Integrity in the Central Nervous System , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[203] C. Dickey,et al. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy , 2015, Acta neuropathologica communications.
[204] Arthur W. Toga,et al. Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.
[205] S. Seaman,et al. GPR124 functions as a WNT7-specific coactivator of canonical β-catenin signaling. , 2015, Cell reports.
[206] A. Goate,et al. Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis , 2015, Biological Psychiatry.
[207] F. Calon,et al. Human Apolipoprotein E ε4 Expression Impairs Cerebral Vascularization and Blood—Brain Barrier Function in Mice , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[208] L. Calderón-Garcidueñas,et al. Air pollution and children: neural and tight junction antibodies and combustion metals, the role of barrier breakdown and brain immunity in neurodegeneration. , 2014, Journal of Alzheimer's disease : JAD.
[209] Hongtu Zhu,et al. Decreases in Short Term Memory, IQ, and Altered Brain Metabolic Ratios in Urban Apolipoprotein ε4 Children Exposed to Air Pollution. , 2015, Journal of Alzheimer's disease : JAD.
[210] N. Bray. Biologics: Transferrin' bispecific antibodies across the blood–brain barrier , 2014, Nature Reviews Drug Discovery.
[211] R. Daneman,et al. The blood-brain barrier. , 2015, Cold Spring Harbor perspectives in biology.
[212] S. Vavricka,et al. Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS , 2014, Pflügers Archiv - European Journal of Physiology.
[213] M. Barbagallo,et al. Type 2 diabetes mellitus and Alzheimer's disease. , 2014, World journal of diabetes.
[214] S. Hladky,et al. Mechanisms of fluid movement into, through and out of the brain: evaluation of the evidence , 2014, Fluids and Barriers of the CNS.
[215] W. Banks,et al. Alpha synuclein is transported into and out of the brain by the blood–brain barrier , 2014, Peptides.
[216] C. V. Van Itallie,et al. Architecture of tight junctions and principles of molecular composition. , 2014, Seminars in cell & developmental biology.
[217] Guo-Yuan Yang,et al. Mesenchymal Stem Cells Maintain Blood‐Brain Barrier Integrity by Inhibiting Aquaporin‐4 Upregulation After Cerebral Ischemia , 2014, Stem cells.
[218] Lai Guan Ng,et al. The gut microbiota influences blood-brain barrier permeability in mice , 2014, Science Translational Medicine.
[219] Xiwei Shan,et al. The Extracellular Matrix Protein Laminin α2 Regulates the Maturation and Function of the Blood–Brain Barrier , 2014, The Journal of Neuroscience.
[220] Jin-Tai Yu,et al. The role of the LRRK2 gene in Parkinsonism , 2014, Molecular Neurodegeneration.
[221] K. Scearce-Levie,et al. Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates , 2014, Science Translational Medicine.
[222] D. Werring,et al. Cerebral small vessel disease-related protease HtrA1 processes latent TGF-β binding protein 1 and facilitates TGF-β signaling , 2014, Proceedings of the National Academy of Sciences.
[223] G. Ortiz,et al. Role of the blood-brain barrier in multiple sclerosis. , 2014, Archives of medical research.
[224] T. Goldberg,et al. APOE2 enhances neuroprotection against Alzheimer’s disease through multiple molecular mechanisms , 2014, Molecular Psychiatry.
[225] W. Pan,et al. Sleep Restriction Impairs Blood–Brain Barrier Function , 2014, The Journal of Neuroscience.
[226] J. Nathans,et al. Gpr124 controls CNS angiogenesis and blood-brain barrier integrity by promoting ligand-specific canonical wnt signaling. , 2014, Developmental cell.
[227] D. Reich,et al. The formation of inflammatory demyelinated lesions in cerebral white matter , 2014, Annals of neurology.
[228] H. Larsson,et al. Accurate Determination of Blood–Brain Barrier Permeability Using Dynamic Contrast-Enhanced T1-Weighted MRI: A Simulation and in vivo Study on Healthy Subjects and Multiple Sclerosis Patients , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[229] D. Hovda,et al. The New Neurometabolic Cascade of Concussion. , 2014, Neurosurgery.
[230] M. Leptin,et al. Molecular mechanisms of de novo lumen formation , 2014, Nature Reviews Molecular Cell Biology.
[231] G. Terwindt,et al. Amyloid β in hereditary cerebral hemorrhage with amyloidosis-Dutch type , 2014, Reviews in the neurosciences.
[232] G. Spalletta,et al. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood–brain barrier integrity , 2014, Molecular Psychiatry.
[233] E. Aronica,et al. Role of blood–brain barrier in temporal lobe epilepsy and pharmacoresistance , 2014, Neuroscience.
[234] D. Wechsler,et al. PICALM modulates autophagy activity and tau accumulation , 2014, Nature Communications.
[235] M. Wolfe,et al. Alzheimer Presenilin-1 Mutations Dramatically Reduce Trimming of Long Amyloid β-Peptides (Aβ) by γ-Secretase to Increase 42-to-40-Residue Aβ* , 2014, The Journal of Biological Chemistry.
[236] H. Gendelman,et al. Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins. , 2014, Nanomedicine.
[237] T. Maniatis,et al. An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.
[238] L. D. Costa,et al. Sensory-Related Neural Activity Regulates the Structure of Vascular Networks in the Cerebral Cortex , 2014, Neuron.
[239] J. Nathans,et al. Canonical WNT signaling components in vascular development and barrier formation. , 2014, The Journal of clinical investigation.
[240] M. Viitanen,et al. CADASIL and CARASIL , 2014, Brain pathology.
[241] Honghong Yao,et al. Tat 101-Mediated Enhancement of Brain Pericyte Migration Involves Platelet-Derived Growth Factor Subunit B Homodimer: Implications for Human Immunodeficiency Virus-Associated Neurocognitive Disorders , 2014, The Journal of Neuroscience.
[242] R. Keep,et al. Vascular disruption and blood–brain barrier dysfunction in intracerebral hemorrhage , 2014, Fluids and Barriers of the CNS.
[243] B. Engelhardt,et al. PSGL‐1 and E/P‐selectins are essential for T‐cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE , 2014, European journal of immunology.
[244] A. Annapragada,et al. Cerebral Vascular Leak in a Mouse Model of Amyloid Neuropathology , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[245] R. Stern,et al. Current Understanding of Chronic Traumatic Encephalopathy , 2014, Current Treatment Options in Neurology.
[246] T. J. Cook,et al. Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease , 2014, Acta Neuropathologica.
[247] F. O’Sullivan,et al. Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood–Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease , 2014, The Journal of Nuclear Medicine.
[248] A. Goate,et al. Alzheimer’s Disease Genetics: From the Bench to the Clinic , 2014, Neuron.
[249] Diego Mantovani,et al. Mutant huntingtin is present in neuronal grafts in huntington disease patients , 2014, Annals of neurology.
[250] Y. Sohn,et al. Cerebral microbleeds in patients with Parkinson’s disease , 2014, Journal of Neurology.
[251] Chao Xu,et al. Crystal structure of the human glucose transporter GLUT1 , 2014, Nature.
[252] C. Power,et al. Allopregnanolone and neuroinflammation: a focus on multiple sclerosis , 2014, Front. Cell. Neurosci..
[253] P. Altevogt,et al. Extracellular Vesicle-Mediated Transfer of Genetic Information between the Hematopoietic System and the Brain in Response to Inflammation , 2014, Journal of Neuroimmunology.
[254] Matthew B. Bouchard,et al. A Critical Role for the Vascular Endothelium in Functional Neurovascular Coupling in the Brain , 2014, Journal of the American Heart Association.
[255] C. Betsholtz. Physiology: Double function at the blood–brain barrier , 2014, Nature.
[256] P. Wong,et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid , 2014, Nature.
[257] Yoav Mayshar,et al. Mfsd2a is critical for the formation and function of the blood–brain barrier , 2014, Nature.
[258] B. Zlokovic,et al. Blood-Brain Barrier: A Dual Life of MFSD2A? , 2014, Neuron.
[259] Breanna K. Wallace,et al. Ischemic factor-induced increases in cerebral microvascular endothelial cell Na/H exchange activity and abundance: evidence for involvement of ERK1/2 MAP kinase. , 2014, American journal of physiology. Cell physiology.
[260] D. Irwin,et al. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD , 2014, Acta Neuropathologica.
[261] A. Nimmerjahn,et al. Stepwise Recruitment of Transcellular and Paracellular Pathways Underlies Blood-Brain Barrier Breakdown in Stroke , 2014, Neuron.
[262] G. Lenzi,et al. Familial Alzheimer's disease sustained by presenilin 2 mutations: Systematic review of literature and genotype–phenotype correlation , 2014, Neuroscience & Biobehavioral Reviews.
[263] J. Kreuter,et al. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? , 2014, Advanced drug delivery reviews.
[264] V. Darras,et al. Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis. , 2014, The Journal of clinical investigation.
[265] Elisa E Konofagou,et al. The Size of Blood–Brain Barrier Opening Induced by Focused Ultrasound is Dictated by the Acoustic Pressure , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[266] Olivier Salvado,et al. Incidence of cerebral microbleeds in preclinical Alzheimer disease , 2014, Neurology.
[267] D. Attwell,et al. Capillary pericytes regulate cerebral blood flow in health and disease , 2014, Nature.
[268] P. Ronaldson,et al. Hypoxia/Reoxygenation Stress Signals an Increase in Organic Anion Transporting polypeptide 1a4 (Oatp1a4) at the Blood–Brain Barrier: Relevance to CNS Drug Delivery , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[269] Manuel A. Friese,et al. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis , 2014, Nature Reviews Neurology.
[270] F. Schmitt,et al. Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models , 2014, Front. Genet..
[271] Patrick G. Shaw,et al. C9orf72 Nucleotide Repeat Structures Initiate Molecular Cascades of Disease , 2014, Nature.
[272] Jesse D. Sengillo,et al. Blood–spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice , 2014, Proceedings of the National Academy of Sciences.
[273] S. Strickland,et al. Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity , 2014, Nature Communications.
[274] B. Imhof,et al. Tight junction dynamics: the role of junctional adhesion molecules (JAMs) , 2014, Cell and Tissue Research.
[275] A. Zarbock,et al. Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin , 2014, Nature Immunology.
[276] W. M. van der Flier,et al. Prevalence of cortical superficial siderosis in a memory clinic population , 2014, Neurology.
[277] D. Fuchs,et al. Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients , 2014, PloS one.
[278] M. Turner,et al. T2-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[279] W. Pardridge,et al. Re-engineering iduronate 2-sulfatase for penetration of the blood-brain barrier via transport on the insulin receptor , 2014 .
[280] J. Alvarez-Linera,et al. Pattern of and Risk Factors for Brain Microbleeds in Neurodegenerative Dementia , 2014, American journal of Alzheimer's disease and other dementias.
[281] Anirvan Ghosh,et al. Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle , 2014, Neuron.
[282] E. Rostrup,et al. Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI☆☆☆ , 2013, NeuroImage: Clinical.
[283] J. Grutzendler,et al. Perturbed neural activity disrupts cerebral angiogenesis during a postnatal critical period , 2013, Nature.
[284] Alexander Leemans,et al. Multiple microbleeds are related to cerebral network disruptions in patients with early Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[285] Jinsha Huang,et al. The Role of LRRK2 in the Regulation of Monocyte Adhesion to Endothelial Cells , 2014, Journal of Molecular Neuroscience.
[286] A. Eichmann. Molecular Parallels between Neural and Vascular Development , 2015, Cold Spring Harbor perspectives in medicine.
[287] B. Zlokovic,et al. Pericyte loss influences Alzheimer-like neurodegeneration in mice , 2013, Nature Communications.
[288] J. Siegenthaler,et al. ‘Sealing off the CNS’: cellular and molecular regulation of blood–brain barriergenesis , 2013, Current Opinion in Neurobiology.
[289] Chiao-Chi V. Chen,et al. Neurovascular abnormalities in humans and mice with Huntington's disease , 2013, Experimental Neurology.
[290] R. Ransohoff,et al. Development, maintenance and disruption of the blood-brain barrier , 2013, Nature Medicine.
[291] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[292] B. Hyman,et al. Gene Transfer of Human Apoe Isoforms Results in Differential Modulation of Amyloid Deposition and Neurotoxicity in Mouse Brain , 2013, Science Translational Medicine.
[293] C. Iadecola,et al. The Pathobiology of Vascular Dementia , 2013, Neuron.
[294] Nick C Fox,et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease , 2013, Proceedings of the National Academy of Sciences.
[295] Chad A. Mirkin,et al. Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma , 2013, Science Translational Medicine.
[296] L. Petrucelli,et al. Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion , 2013, Science Translational Medicine.
[297] Daniel J. R. Christensen,et al. Sleep Drives Metabolite Clearance from the Adult Brain , 2013, Science.
[298] Nipun A. Mistry,et al. RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention , 2013, Neuron.
[299] D. Harold,et al. Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome , 2013, Neurobiology of Aging.
[300] Yuan Tian,et al. Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy , 2013, Proceedings of the National Academy of Sciences.
[301] R. Carare,et al. MK886 Reduces Cerebral Amyloid Angiopathy Severity in TgCRND8 Mice , 2013, Neurodegenerative Diseases.
[302] T. Terasaki,et al. Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset. , 2013, Journal of pharmaceutical sciences.
[303] D. Geschwind,et al. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice , 2013, Nature Genetics.
[304] N. Pomara,et al. Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown. , 2013, JAMA neurology.
[305] J. Trojanowski,et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. , 2013, Brain : a journal of neurology.
[306] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[307] R. Touraine,et al. Relevance of Different Cellular Models in Determining the Effects of Mutations on SLC16A2/MCT8 Thyroid Hormone Transporter Function and Genotype–Phenotype Correlation , 2013, Human mutation.
[308] J. Briscoe,et al. The mechanisms of Hedgehog signalling and its roles in development and disease , 2013, Nature Reviews Molecular Cell Biology.
[309] L. Ferrarini,et al. EndMT contributes to the onset and progression of cerebral cavernous malformations , 2013, Nature.
[310] S. Maeng,et al. MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease , 2013, Mediators of inflammation.
[311] Joanes Grandjean,et al. Longitudinal Assessment of Amyloid Pathology in Transgenic ArcAβ Mice Using Multi-Parametric Magnetic Resonance Imaging , 2013, PloS one.
[312] Tammie L. S. Benzinger,et al. Increased in Vivo Amyloid-β42 Production, Exchange, and Loss in Presenilin Mutation Carriers , 2013, Science Translational Medicine.
[313] M. Sabbagh,et al. Neurochemical profile of dementia pugilistica. , 2013, Journal of neurotrauma.
[314] P. Nordlund,et al. Structural basis for substrate transport in the GLUT-homology family of monosaccharide transporters , 2013, Nature Structural &Molecular Biology.
[315] S. Strickland,et al. The APOE ε4/ε4 Genotype Potentiates Vascular Fibrin(Ogen) Deposition in Amyloid-Laden Vessels in the Brains of Alzheimer's Disease Patients , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[316] A. Paetau,et al. Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population , 2013, Neurobiology of Aging.
[317] J. Zalvide,et al. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. , 2013, Trends in molecular medicine.
[318] Mahlon D. Johnson,et al. Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in Alzheimer's Disease , 2013, Brain pathology.
[319] T. Hirai,et al. Prevalence and Topography of Small Hypointense Foci Suggesting Microbleeds on 3T Susceptibility-Weighted Imaging in Various Types of Dementia , 2013, American Journal of Neuroradiology.
[320] H. D. de Vries,et al. MicroRNAs Regulate Human Brain Endothelial Cell-Barrier Function in Inflammation: Implications for Multiple Sclerosis , 2013, The Journal of Neuroscience.
[321] H. Tomimoto,et al. Clinical and neuropathological findings in a patient with familial Alzheimer disease showing a mutation in the PSEN1 gene , 2013, Neuropathology : official journal of the Japanese Society of Neuropathology.
[322] B. Zlokovic. Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. , 2013, JAMA neurology.
[323] S. Taheri,et al. Quantification of blood-to-brain transfer rate in multiple sclerosis. , 2013, Multiple sclerosis and related disorders.
[324] C. Walsh,et al. Delineation of the Clinical, Molecular and Cellular Aspects of Novel JAM3 Mutations Underlying the Autosomal Recessive Hemorrhagic Destruction of the Brain, Subependymal Calcification, and Congenital Cataracts , 2013, Human mutation.
[325] G. Alexander,et al. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. , 2013, JAMA neurology.
[326] T. Videen,et al. Cerebral blood flow responses to dorsal and ventral STN DBS correlate with gait and balance responses in Parkinson's disease , 2013, Experimental Neurology.
[327] E. Wright,et al. Regional distribution of SGLT activity in rat brain in vivo. , 2013, American journal of physiology. Cell physiology.
[328] Huaxi Xu,et al. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.
[329] W. M. van der Flier,et al. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia , 2013, Neurology.
[330] A. Singleton,et al. TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.
[331] A. Hofman,et al. Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.
[332] L. Defebvre,et al. Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification , 2013, Neurology.
[333] C. Iadecola,et al. Brain and Circulating Levels of A&bgr;1–40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain , 2013, Stroke.
[334] E. Dejana,et al. The role of VE-cadherin in vascular morphogenesis and permeability control. , 2013, Progress in molecular biology and translational science.
[335] J. Nathans,et al. Norrin/Frizzled4 Signaling in Retinal Vascular Development and Blood Brain Barrier Plasticity , 2012, Cell.
[336] R. Mahley,et al. Apolipoprotein E Sets the Stage: Response to Injury Triggers Neuropathology , 2012, Neuron.
[337] B. Engelhardt,et al. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. , 2012, Trends in immunology.
[338] L. Nikolić,et al. Changes in the astrocytic aquaporin‐4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1G93A rat model , 2012, Glia.
[339] T. Deerinck,et al. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation , 2012, Nature Communications.
[340] Stavros J. Baloyannis,et al. The vascular factor in Alzheimer's disease: A study in Golgi technique and electron microscopy , 2012, Journal of the Neurological Sciences.
[341] H. Schiöth,et al. Intranasal Treatment of Central Nervous System Dysfunction in Humans , 2012, Pharmaceutical Research.
[342] C. Jack,et al. Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative , 2012, Alzheimer's & Dementia.
[343] Oliver Braganza,et al. Albumin is taken up by hippocampal NG2 cells and astrocytes and decreases gap junction coupling , 2012, Epilepsia.
[344] W. Pardridge,et al. Drug Transport across the Blood–Brain Barrier , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[345] D. Kaufer,et al. Blood–brain barrier dysfunction–induced inflammatory signaling in brain pathology and epileptogenesis , 2012, Epilepsia.
[346] Axel Montagne,et al. Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders , 2012, NeuroImage.
[347] Xinqi Gong,et al. Crystal structure of a bacterial homologue of glucose transporters GLUT1–4 , 2012, Nature.
[348] R. Tanzi. The genetics of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[349] V. Janardhan,et al. Blood–brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke , 2012, Neurology.
[350] K. Plate,et al. Junctional Adhesion Molecule (JAM)-C Deficient C57BL/6 Mice Develop a Severe Hydrocephalus , 2012, PloS one.
[351] Aaron J. Johnson,et al. Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability , 2012, Journal of Neuroinflammation.
[352] H. Chneiweiss,et al. Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation , 2012, Journal of Cell Science.
[353] Jesse D. Sengillo,et al. Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis , 2012, Acta Neuropathologica.
[354] Nick C Fox,et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.
[355] Paul R. Sanberg,et al. Impaired blood–brain/spinal cord barrier in ALS patients , 2012, Brain Research.
[356] C. Labelle-Dumais,et al. COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets , 2012, Human molecular genetics.
[357] G. E. Vates,et al. A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β , 2012, Science Translational Medicine.
[358] A. Pisani,et al. Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease , 2012, Journal of Neuroinflammation.
[359] Ole A. Andreassen,et al. A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.
[360] Jesse D. Sengillo,et al. Blood–spinal cord barrier pericyte reductions contribute to increased capillary permeability , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[361] R. Keep,et al. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets , 2012, The Lancet Neurology.
[362] Jeremy Seto,et al. Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. , 2012, The Journal of clinical investigation.
[363] J. Parratt,et al. Oligodendrocytes and the early multiple sclerosis lesion , 2012, Annals of neurology.
[364] M. Ehrich,et al. Malathion/Oxon and Lead Acetate Increase Gene Expression and Protein Levels of Transient Receptor Potential Canonical Channel Subunits TRPC1 and TRPC4 in Rat Endothelial Cells of the Blood–Brain Barrier , 2012, International journal of toxicology.
[365] Stanley E. Lazic,et al. Transcriptional Profiling of Human Brain Endothelial Cells Reveals Key Properties Crucial for Predictive In Vitro Blood-Brain Barrier Models , 2012, PloS one.
[366] Berislav V. Zlokovic,et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A , 2012, Nature.
[367] J. Kaye,et al. Dyslipidemia and Blood-Brain Barrier Integrity in Alzheimer's Disease , 2012, Current gerontology and geriatrics research.
[368] Thomas Dalsgaard,et al. Elementary Ca2+signals through endothelial TRPV4 channels regulate vascular function , 2013, BMC Pharmacology and Toxicology.
[369] C. Huang,et al. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta‐analysis of longitudinal studies , 2012, Internal medicine journal.
[370] Qingli Xiao,et al. Role of Phosphatidylinositol Clathrin Assembly Lymphoid-Myeloid Leukemia (PICALM) in Intracellular Amyloid Precursor Protein (APP) Processing and Amyloid Plaque Pathogenesis* , 2012, The Journal of Biological Chemistry.
[371] Jeff H. Duyn,et al. Iron Accumulation in Deep Cortical Layers Accounts for MRI Signal Abnormalities in ALS: Correlating 7 Tesla MRI and Pathology , 2012, PloS one.
[372] B. de Strooper,et al. The mechanism of γ-Secretase dysfunction in familial Alzheimer disease , 2012, The EMBO journal.
[373] M. Cohen-Salmon,et al. Deletion of Astroglial Connexins Weakens the Blood–Brain Barrier , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[374] Nathan T. Ross,et al. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. , 2012, The Journal of clinical investigation.
[375] C. Brosnan,et al. Loss of astrocyte connexins 43 and 30 does not significantly alter susceptibility or severity of acute experimental autoimmune encephalomyelitis in mice , 2012, Journal of Neuroimmunology.
[376] Guojun Bu,et al. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[377] Joshua S Kaminker,et al. Death receptors DR6 and TROY regulate brain vascular development. , 2012, Developmental cell.
[378] Peter R Luijten,et al. High prevalence of cerebral microbleeds at 7Tesla MRI in patients with early Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[379] W. M. van der Flier,et al. Blood-brain barrier p-glycoprotein function in Alzheimer's disease , 2011, Alzheimer's & Dementia.
[380] F. Charron,et al. The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence , 2011, Science.
[381] D. Holtzman,et al. Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis , 2011, The Journal of Neuroscience.
[382] Anand Viswanathan,et al. Cerebral amyloid angiopathy in the elderly , 2011, Annals of neurology.
[383] J. Reichenbach,et al. Detection of Cerebral Microbleeds with Quantitative Susceptibility Mapping in the Arcabeta Mouse Model of Cerebral Amyloidosis , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[384] B. Zlokovic. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.
[385] Sharon E. Miller,et al. The Molecular Basis for the Endocytosis of Small R-SNAREs by the Clathrin Adaptor CALM , 2011, Cell.
[386] K. M. Baeten,et al. Extracellular matrix and matrix receptors in blood–brain barrier formation and stroke , 2011, Developmental neurobiology.
[387] B. Zlokovic,et al. Central nervous system pericytes in health and disease , 2011, Nature Neuroscience.
[388] Michael Sendtner,et al. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis , 2011, Nature Reviews Neurology.
[389] M. Wolfe,et al. Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations. , 2011, Biochemistry.
[390] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[391] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[392] Ammar Al-Chalabi,et al. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? , 2011, Nature Reviews Neurology.
[393] B. Engelhardt,et al. Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis , 2011, Acta Neuropathologica.
[394] Eric M Reiman,et al. Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast , 2011, Science.
[395] Holger Gerhardt,et al. Basic and Therapeutic Aspects of Angiogenesis , 2011, Cell.
[396] Didier Y. R. Stainier,et al. Molecular control of endothelial cell behaviour during blood vessel morphogenesis , 2011, Nature Reviews Molecular Cell Biology.
[397] C. Betsholtz,et al. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.
[398] P. Grammas,et al. Brain microvasculature and hypoxia-related proteins in Alzheimer's disease. , 2011, International journal of clinical and experimental pathology.
[399] M. Nonnemacher,et al. Breaking down the barrier: The effects of HIV-1 on the blood–brain barrier , 2011, Brain Research.
[400] Daniel S Reich,et al. Evolution of the blood–brain barrier in newly forming multiple sclerosis lesions , 2011, Annals of neurology.
[401] Cindee M. Madison,et al. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI , 2011, Neurobiology of Aging.
[402] David M Holtzman,et al. Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance , 2011, Science Translational Medicine.
[403] E. Meyer,et al. Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice , 2011, Acta Neuropathologica.
[404] K. Scearce-Levie,et al. A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo , 2011, Science Translational Medicine.
[405] P. Bosco,et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance , 2011, Molecular Psychiatry.
[406] K. Abe,et al. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis , 2011, Journal of neuroscience research.
[407] Donald W. Miller,et al. Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells , 2011, Journal of neurochemistry.
[408] Dorian B. McGavern,et al. Illuminating viral infections in the nervous system , 2011, Nature Reviews Immunology.
[409] G. Bu,et al. Apolipoprotein E Regulates the Integrity of Tight Junctions in an Isoform-dependent Manner in an in Vitro Blood-Brain Barrier Model* , 2011, The Journal of Biological Chemistry.
[410] Nick C Fox,et al. Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.
[411] Takashi Suzuki,et al. Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptors , 2011, Journal of neurochemistry.
[412] J. Griffin,et al. Cytoprotective protein C pathways and implications for stroke and neurological disorders , 2011, Trends in Neurosciences.
[413] M. Wood,et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.
[414] D. Janigro,et al. Efficacy of Anti-Inflammatory Therapy in a Model of Acute Seizures and in a Population of Pediatric Drug Resistant Epileptics , 2011, PloS one.
[415] K. Nagashima,et al. GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood–brain barrier , 2011, Proceedings of the National Academy of Sciences.
[416] O. Hardiman,et al. Amyotrophic lateral sclerosis , 2011, The Lancet.
[417] G. Bačić,et al. Imaging cellular markers of neuroinflammation in the brain of the rat model of amyotrophic lateral sclerosis. , 2011, Acta physiologica Hungarica.
[418] D. Holtzman,et al. Apolipoprotein E in Alzheimer's disease and other neurological disorders , 2011, The Lancet Neurology.
[419] Yadong Huang,et al. C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-β (Aβ) and acts in concert with Aβ to elicit neuronal and behavioral deficits in mice , 2011, Proceedings of the National Academy of Sciences.
[420] A. Prat,et al. Disruption of central nervous system barriers in multiple sclerosis. , 2011, Biochimica et biophysica acta.
[421] B. Engelhardt,et al. Review: Leucocyte–endothelial cell crosstalk at the blood–brain barrier: A prerequisite for successful immune cell entry to the brain , 2011, Neuropathology and applied neurobiology.
[422] Marta P Pereira,et al. Transplanted Stem Cell‐Secreted Vascular Endothelial Growth Factor Effects Poststroke Recovery, Inflammation, and Vascular Repair , 2011, Stem Cells.
[423] Johnathon R. Walls,et al. Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor , 2011, Proceedings of the National Academy of Sciences.
[424] M. Staufenbiel,et al. Noninvasive Magnetic Resonance Imaging Detection of Cerebral Amyloid Angiopathy-Related Microvascular Alterations Using Superparamagnetic Iron Oxide Particles in APP Transgenic Mouse Models of Alzheimer's Disease: Application to Passive Aβ Immunotherapy , 2011, The Journal of Neuroscience.
[425] Sandro Sorbi,et al. Meta-analysis of the association between variants in SORL1 and Alzheimer disease. , 2011, Archives of neurology.
[426] Chengjie Xiong,et al. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease , 2011, Alzheimer's Research & Therapy.
[427] Tallie Z. Baram,et al. The role of inflammation in epilepsy , 2011, Nature Reviews Neurology.
[428] Julie A. Schneider,et al. Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsy , 2011, Journal of Neural Transmission.
[429] Sachin Dixit,et al. APOE4 Allele Disrupts Resting State fMRI Connectivity in the Absence of Amyloid Plaques or Decreased CSF Aβ42 , 2010, The Journal of Neuroscience.
[430] Ulrich Dirnagl,et al. Pericytes in capillaries are contractile in vivo, but arterioles mediate functional hyperemia in the mouse brain , 2010, Proceedings of the National Academy of Sciences.
[431] R. Deane,et al. Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brain , 2010, Journal of neurochemistry.
[432] B. Barres,et al. Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.
[433] Bengt R. Johansson,et al. Pericytes regulate the blood–brain barrier , 2010, Nature.
[434] M. P. van den Heuvel,et al. No evidence of microbleeds in ALS patients at 7 Tesla MRI , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[435] Hua Su,et al. Essential Regulation of CNS Angiogenesis by the Orphan G Protein–Coupled Receptor GPR124 , 2010, Science.
[436] Berislav V. Zlokovic,et al. Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.
[437] D. Stein,et al. Progesterone and allopregnanolone attenuate blood–brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases , 2010, Experimental Neurology.
[438] B. Barres,et al. The Mouse Blood-Brain Barrier Transcriptome: A New Resource for Understanding the Development and Function of Brain Endothelial Cells , 2010, PloS one.
[439] B. Engelhardt,et al. Differential Roles for Endothelial ICAM-1, ICAM-2, and VCAM-1 in Shear-Resistant T Cell Arrest, Polarization, and Directed Crawling on Blood–Brain Barrier Endothelium , 2010, The Journal of Immunology.
[440] Elisabetta Dejana,et al. The Role of Wnt Signaling in Physiological and Pathological Angiogenesis , 2010, Circulation research.
[441] Y. Crow,et al. Recessive mutations in the gene encoding the tight junction protein occludin cause band-like calcification with simplified gyration and polymicrogyria. , 2010, American journal of human genetics.
[442] J. Bailes,et al. Chronic traumatic encephalopathy in a professional American wrestler , 2010, Journal of forensic nursing.
[443] Kewei Chen,et al. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. , 2010, Human molecular genetics.
[444] J. Cooke,et al. Stem Cell Therapy for Vascular Regeneration: Adult, Embryonic, and Induced Pluripotent Stem Cells , 2010, Circulation.
[445] H. Liou,et al. Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood‐brain barrier and MPTP‐induced dopaminergic toxicity in rodents , 2010, Journal of neurochemistry.
[446] V. Pankratz,et al. Replication of CLU, CR1, and PICALM associations with alzheimer disease. , 2010, Archives of neurology.
[447] Alon Friedman,et al. Blood–brain barrier breakdown as a therapeutic target in traumatic brain injury , 2010, Nature Reviews Neurology.
[448] S. Strickland,et al. Fibrinogen and β-Amyloid Association Alters Thrombosis and Fibrinolysis: A Possible Contributing Factor to Alzheimer's Disease , 2010, Neuron.
[449] Rachel C Brown,et al. TRPC-mediated actin-myosin contraction is critical for BBB disruption following hypoxic stress. , 2010, American journal of physiology. Cell physiology.
[450] Sudha Seshadri,et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.
[451] D. Attwell,et al. Pericyte-Mediated Regulation of Capillary Diameter: A Component of Neurovascular Coupling in Health and Disease , 2010, Front. Neuroenerg..
[452] Ilona B. Bruinsma,et al. Apolipoprotein E protects cultured pericytes and astrocytes from D-Aβ1–40-mediated cell death , 2010, Brain Research.
[453] V. Nerurkar,et al. Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor. , 2010, Virology.
[454] David J. Begley,et al. Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.
[455] Michael S. Becker,et al. Beta1 integrin establishes endothelial cell polarity and arteriolar lumen formation via a Par3-dependent mechanism. , 2010, Developmental cell.
[456] P. Hof,et al. Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations. , 2010, The American journal of pathology.
[457] S. Resnick,et al. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. , 2010, Archives of neurology.
[458] D. Cleveland,et al. Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond , 2009, The Journal of cell biology.
[459] G. Vanhoutte,et al. In Vivo Morphological Changes in Animal Models of Amyotrophic Lateral Sclerosis and Alzheimer's‐Like Disease: MRI Approach , 2009, Anatomical record.
[460] P. Demetter,et al. Impaired blood–brain and blood–spinal cord barriers in mutant SOD1-linked ALS rat , 2009, Brain Research.
[461] Lee D. Hallagan,et al. Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. , 2009, The Journal of clinical investigation.
[462] W. M. van der Flier,et al. Patients With Alzheimer Disease With Multiple Microbleeds: Relation With Cerebrospinal Fluid Biomarkers and Cognition , 2009, Stroke.
[463] T. Suuronen,et al. Clusterin: A forgotten player in Alzheimer's disease , 2009, Brain Research Reviews.
[464] L. Kiemeney,et al. Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.
[465] Nick C Fox,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.
[466] D. Holtzman,et al. The Role of Apolipoprotein E in Alzheimer's Disease , 2009, Neuron.
[467] Lisa E. Gralinski,et al. Mouse Adenovirus Type 1-Induced Breakdown of the Blood-Brain Barrier , 2009, Journal of Virology.
[468] R. Bowser,et al. DECREASED mRNA EXPRESSION OF TIGHT JUNCTION PROTEINS IN LUMBAR SPINAL CORDS OF PATIENTS WITH ALS , 2009, Neurology.
[469] P. Narayana,et al. Blood–spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast‐enhanced MRI , 2009, NMR in biomedicine.
[470] Joanna Wardlaw,et al. Blood–brain barrier permeability in Alzheimer's disease: a case–control MRI study , 2009, Psychiatry Research: Neuroimaging.
[471] T. Kirchhausen,et al. Lymphocyte crawling and transendothelial migration require chemokine triggering of high-affinity LFA-1 integrin. , 2009, Immunity.
[472] D. Thakker,et al. Intracerebroventricular amyloid-β antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice , 2009, Proceedings of the National Academy of Sciences.
[473] R. Mandel,et al. AAV9: a potential blood-brain barrier buster. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[474] R. Weller,et al. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy , 2009, Acta Neuropathologica.
[475] M. Iruela-Arispe,et al. Cellular and molecular mechanisms of vascular lumen formation. , 2009, Developmental cell.
[476] G. Zoppo. Inflammation and the neurovascular unit in the setting of focal cerebral ischemia , 2009, Neuroscience.
[477] C. Delporte,et al. Aquaporin‐4 Overexpression in Rat ALS Model , 2009, Anatomical record.
[478] R. Deane,et al. SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells , 2009, Nature Cell Biology.
[479] Calvin J Kuo,et al. Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesis , 2009, Proceedings of the National Academy of Sciences.
[480] L. Margaritis,et al. Intracellular Clusterin Inhibits Mitochondrial Apoptosis by Suppressing p53-Activating Stress Signals and Stabilizing the Cytosolic Ku70-Bax Protein Complex , 2009, Clinical Cancer Research.
[481] J. Ryu,et al. A leaky blood–brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease brain , 2008, Journal of cellular and molecular medicine.
[482] Nick C Fox,et al. Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .
[483] R. Armstrong. Spatial correlations between β-amyloid (Aβ) deposits and blood vessels in familial Alzheimer’s disease , 2008 .
[484] C. Kuo,et al. Developmental angiogenesis of the central nervous system. , 2008, Lymphatic research and biology.
[485] E. Tate,et al. Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. , 2008, Endocrinology.
[486] Katie Hamm,et al. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. , 2008, The Journal of clinical investigation.
[487] Andrew P. McMahon,et al. Canonical Wnt Signaling Regulates Organ-Specific Assembly and Differentiation of CNS Vasculature , 2008, Science.
[488] K. Plate,et al. Wnt/β-catenin signaling controls development of the blood–brain barrier , 2008, The Journal of cell biology.
[489] J. Geiger,et al. Caffeine protects against MPTP‐induced blood‐brain barrier dysfunction in mouse striatum , 2008, Journal of neurochemistry.
[490] P. Couraud,et al. Alteration of Blood–Brain Barrier Integrity by Retroviral Infection , 2008, PLoS pathogens.
[491] Miles C. Miller,et al. Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease , 2008, Brain Research.
[492] D. Holtzman,et al. ApoE Promotes the Proteolytic Degradation of Aβ , 2008, Neuron.
[493] Joshua D. Wythe,et al. Corrigendum: Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability , 2008, Nature Medicine.
[494] G. Schellenberg,et al. Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease. , 2008, Archives of neurology.
[495] R. Deane,et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration , 2008, Nature Neuroscience.
[496] E. Reiman,et al. Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.
[497] T. Kiyota,et al. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. , 2008, The American journal of pathology.
[498] B. Zlokovic. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.
[499] Anthony R. Calabria,et al. A Genomic Comparison of in vivo and in vitro Brain Microvascular Endothelial Cells , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[500] M. Lampugnani,et al. Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration , 2008, Journal of Cell Science.
[501] R. Keep,et al. Blood-brain barrier function in intracerebral hemorrhage. , 2008, Acta neurochirurgica. Supplement.
[502] S. Hladky,et al. Kv1 and Kir2 potassium channels are expressed in rat brain endothelial cells , 2008, Pflügers Archiv - European Journal of Physiology.
[503] A. Leszczynska,et al. Small cerebral vessel disease in familial amyloid and non-amyloid angiopathies: FAD-PS-1 (P117L) mutation and CADASIL. Immunohistochemical and ultrastructural studies. , 2007, Folia neuropathologica.
[504] M. Verbeek,et al. Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells. , 2007, The American journal of pathology.
[505] E. Haller,et al. Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS , 2007, PloS one.
[506] Bernardino Ghetti,et al. The Genetics of Very Early Onset Alzheimer Disease , 2007, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.
[507] A. Goate,et al. Clearance of amyloid-β by circulating lipoprotein receptors , 2007, Nature Medicine.
[508] Kuixing Zhang,et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. , 2007, The New England journal of medicine.
[509] J. Melchor,et al. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. , 2007 .
[510] Uwe Haberkorn,et al. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease , 2007, Psychiatry Research: Neuroimaging.
[511] Benjamin D. Sachs,et al. Fibrinogen inhibits neurite outgrowth via β3 integrin-mediated phosphorylation of the EGF receptor , 2007, Proceedings of the National Academy of Sciences.
[512] S. Nicosia,et al. Ultrastructure of blood–brain barrier and blood–spinal cord barrier in SOD1 mice modeling ALS , 2007, Brain Research.
[513] T. Berzin,et al. Microvascular injury and blood–brain barrier leakage in Alzheimer's disease , 2007, Neurobiology of Aging.
[514] Philippe Coubes,et al. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. , 2007, Brain : a journal of neurology.
[515] V. Valcour,et al. Small-Vessel Vascular Disease in Human Immunodeficiency Virus Infection: The Hawaii Aging with HIV Cohort Study , 2007, Cerebrovascular Diseases.
[516] S. Vannucci,et al. Supply and Demand in Cerebral Energy Metabolism: The Role of Nutrient Transporters , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[517] J. Cano,et al. Blood–brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons , 2007, Journal of neurochemistry.
[518] J. LaManna,et al. Diet-induced ketosis increases capillary density without altered blood flow in rat brain. , 2007, American journal of physiology. Endocrinology and metabolism.
[519] H. Matsuda,et al. Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer’s disease , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[520] D. Holtzman,et al. Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[521] D. Shreiber,et al. Immediate damage to the blood-spinal cord barrier due to mechanical trauma. , 2007, Journal of neurotrauma.
[522] P. Carvey,et al. TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice , 2007, Neurobiology of Disease.
[523] A. Hafezi-Moghadam,et al. ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage. , 2007, American journal of physiology. Cell physiology.
[524] S. McQuaid,et al. Persistent endothelial abnormalities and blood–brain barrier leak in primary and secondary progressive multiple sclerosis , 2007, Neuropathology and applied neurobiology.
[525] Alon Friedman,et al. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. , 2007, Brain : a journal of neurology.
[526] K. Lunetta,et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.
[527] E. Aronica,et al. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. , 2007, Brain : a journal of neurology.
[528] C. Ek,et al. Changes in blood–brain barrier permeability to large and small molecules following traumatic brain injury in mice , 2007, The European journal of neuroscience.
[529] M. D. de Leon,et al. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[530] S. Hladky,et al. Transporters involved in regulation of intracellular pH in primary cultured rat brain endothelial cells , 2006, The Journal of physiology.
[531] D. Attwell,et al. Bidirectional control of CNS capillary diameter by pericytes , 2006, Nature.
[532] R. Tamargo,et al. Inflammation in stroke and focal cerebral ischemia. , 2006, Surgical neurology.
[533] E. Golob,et al. Vascular volume and blood‐brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls , 2006, Journal of magnetic resonance imaging : JMRI.
[534] Robert H. Brown,et al. Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.
[535] Minoru Takemoto,et al. Microarray analysis of blood microvessels from PDGF‐B and PDGF‐Rβ mutant mice identifies novel markers for brain pericytes , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[536] Miles C. Miller,et al. RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease , 2006, Acta Neuropathologica.
[537] Tsuyoshi Saito,et al. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells , 2006, Journal of cellular physiology.
[538] K. Kaibuchi,et al. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). , 2006, Blood.
[539] E. Granieri,et al. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis , 2006, Multiple sclerosis.
[540] Y. Mizuno,et al. Expression levels of vascular endothelial growth factor and its receptors in Parkinson's disease , 2006, Neuroreport.
[541] David Walker,et al. Profile and Regulation of Apolipoprotein E (ApoE) Expression in the CNS in Mice with Targeting of Green Fluorescent Protein Gene to the ApoE Locus , 2006, The Journal of Neuroscience.
[542] J. Gliemann,et al. Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10p-domain receptor family members. , 2006, The Biochemical journal.
[543] J. Sundberg,et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. , 2006, The New England journal of medicine.
[544] A. Ludolph,et al. Axonal damage markers in cerebrospinal fluid are increased in ALS , 2006, Neurology.
[545] M. O’Donnell,et al. Estradiol Reduces Activity of the Blood–Brain Barrier Na–K–Cl Cotransporter and Decreases Edema Formation in Permanent Middle Cerebral Artery Occlusion , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[546] E. Levy,et al. Studies on the first described Alzheimer's disease amyloid beta mutant, the Dutch variant. , 2006, Journal of Alzheimer's disease : JAD.
[547] J. Viña,et al. Structure of the blood-brain barrier and its role in the transport of amino acids. , 2006, The Journal of nutrition.
[548] E. Hansson,et al. Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.
[549] F. Barkhof,et al. Blood–brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis , 2005, Neurobiology of Disease.
[550] M. O’Donnell,et al. Moderate-to-severe ischemic conditions increase activity and phosphorylation of the cerebral microvascular endothelial cell Na+-K+-Cl- cotransporter. , 2005, American journal of physiology. Cell physiology.
[551] A. Fagan,et al. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. , 2005, The Journal of clinical investigation.
[552] P. Meda,et al. Dual interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesion. , 2005, Molecular biology of the cell.
[553] C. Betsholtz,et al. Endothelial/Pericyte Interactions , 2005, Circulation research.
[554] P. Carvey,et al. 6‐Hydroxydopamine‐induced alterations in blood–brain barrier permeability , 2005, The European journal of neuroscience.
[555] P. Hof,et al. Selective expression of presenilin 1 in neural progenitor cells rescues the cerebral hemorrhages and cortical lamination defects in presenilin 1-null mutant mice , 2005, Development.
[556] R. Taichman,et al. Clusterin inhibits apoptosis by interacting with activated Bax , 2005, Nature Cell Biology.
[557] Don L. Armstrong,et al. Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease , 2005, Nature Medicine.
[558] John Hardy,et al. Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. , 2005, The American journal of pathology.
[559] P. Carmeliet,et al. Common mechanisms of nerve and blood vessel wiring , 2005, Nature.
[560] Brian J Bacskai,et al. Progression of Cerebral Amyloid Angiopathy in Transgenic Mouse Models of Alzheimer Disease , 2005, Journal of neuropathology and experimental neurology.
[561] A. Hofman,et al. Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study , 2005, Annals of neurology.
[562] T. Davis,et al. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.
[563] Jonathan Stone,et al. Pericapillary Haem-Rich Deposits: Evidence for Microhaemorrhages in Aging Human Cerebral Cortex , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[564] M. Verbeek,et al. Apolipoprotein E Genotype Regulates Amyloid-β Cytotoxicity , 2005, The Journal of Neuroscience.
[565] D. Holtzman,et al. Human Apolipoprotein E4 Alters the Amyloid-β 40:42 Ratio and Promotes the Formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein Transgenic Model , 2005, The Journal of Neuroscience.
[566] J. Bart,et al. Blood–brain barrier dysfunction in parkinsonian midbrain in vivo , 2005, Annals of neurology.
[567] A. Uitterlinden,et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation , 2004, The Lancet.
[568] E. Masliah,et al. Altered P‐Glycoprotein Expression in AIDS Patients with HIV Encephalitis , 2004, Journal of neuropathology and experimental neurology.
[569] Peter J. Lenting,et al. LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms , 2004, Neuron.
[570] S. D. Fraser,et al. Semaphorin-plexin signaling guides patterning of the developing vasculature. , 2004, Developmental cell.
[571] P. Hof,et al. The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease , 2004, Neurological research.
[572] P. Andreasen,et al. The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand. , 2004, The Biochemical journal.
[573] C. Iadecola. Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[574] O. Witte,et al. Localization of the Na+-d-glucose cotransporter SGLT1 in the blood-brain barrier , 2004, Histochemistry and Cell Biology.
[575] S. Rapoport. Osmotic Opening of the Blood–Brain Barrier: Principles, Mechanism, and Therapeutic Applications , 2000, Cellular and Molecular Neurobiology.
[576] K. Felgenhauer,et al. Serum-CSF protein gradients, the blood-CSF barrier and the local immune response , 1978, Journal of Neurology.
[577] K. Brockmann,et al. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. , 2004, American journal of human genetics.
[578] E. Hirsch,et al. Blood vessels and parkinsonism. , 2004, Frontiers in bioscience : a journal and virtual library.
[579] D. Davies,et al. Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease , 2004, Virchows Archiv.
[580] W. Pardridge. Molecular biology of the blood-brain barrier , 2005, Methods in molecular medicine.
[581] G. Alexander,et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[582] D. Dickstein,et al. Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model , 2003 .
[583] R. Hawkins,et al. Na+-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood-brain barrier. , 2003, American journal of physiology. Endocrinology and metabolism.
[584] Philippe Soriano,et al. Additive Effects of PDGF Receptor β Signaling Pathways in Vascular Smooth Muscle Cell Development , 2003, PLoS biology.
[585] Z. Werb,et al. Blood‐spinal cord barrier after spinal cord injury: Relation to revascularization and wound healing , 2003, Journal of neuroscience research.
[586] S. McQuaid,et al. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood–brain barrier leakage and active demyelination , 2003, The Journal of pathology.
[587] K. Hirschi,et al. Gap Junction Communication Mediates Transforming Growth Factor-&bgr; Activation and Endothelial-Induced Mural Cell Differentiation , 2003, Circulation research.
[588] Hyun Seok Song,et al. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier , 2003, Nature Medicine.
[589] Ann Marie Schmidt,et al. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain , 2003, Nature Medicine.
[590] A. Vorbrodt,et al. Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist’s view , 2003, Brain Research Reviews.
[591] S. Tsukita,et al. Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.
[592] D. Ribatti,et al. Severe alterations of endothelial and glial cells in the blood‐brain barrier of dystrophic mdx mice , 2003, Glia.
[593] A. Hofman,et al. Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.
[594] W. Pardridge,et al. Blood—Brain Barrier Genomics , 2001, Methods in molecular medicine.
[595] L. Sobrevia,et al. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. , 2003, Physiological reviews.
[596] S. Salloway,et al. Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease , 2002, Journal of the Neurological Sciences.
[597] W. Pardridge,et al. Rat Blood–Brain Barrier Genomics. II , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[598] M. Eichelbaum,et al. Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. , 2002, Pharmacogenetics.
[599] Cornelia M van Duijn,et al. Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric. , 2002, The American journal of pathology.
[600] B. Zlokovic,et al. Substitution at codon 22 reduces clearance of Alzheimer’s amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood , 2002, Neurobiology of Aging.
[601] M. Graves,et al. Cyclooxygenase‐2‐positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood–brain barrier , 2002, European journal of clinical investigation.
[602] D D Allen,et al. Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier , 2002, Drug development and industrial pharmacy.
[603] A. Hafezi-Moghadam,et al. ApoE Deficiency Compromises the Blood Brain Barrier Especially After Injury , 2001, Molecular medicine.
[604] R. Roos,et al. Dementia in hereditary cerebral hemorrhage with amyloidosis‐Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles , 2001, Annals of neurology.
[605] M. Cruts,et al. Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation. , 2001, Brain : a journal of neurology.
[606] P. Luiten,et al. Cerebral microvascular pathology in aging and Alzheimer's disease , 2001, Progress in Neurobiology.
[607] A. Blokland,et al. Apolipoprotein E Protects against Neuropathology Induced by a High-Fat Diet and Maintains the Integrity of the Blood-Brain Barrier during Aging , 2001, Laboratory Investigation.
[608] T. Grabowski,et al. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy , 2001, Annals of neurology.
[609] Nick C Fox,et al. Autopsy-confirmed familial early-onset Alzheimer disease caused by the l153V presenilin 1 mutation. , 2001, Archives of neurology.
[610] S. Fullerton,et al. Impairment of the Blood–Nerve and Blood–Brain Barriers in Apolipoprotein E Knockout Mice , 2001, Experimental Neurology.
[611] M. Chopp,et al. Up-Regulation of Neuropilin-1 in Neovasculature after Focal Cerebral Ischemia in the Adult Rat , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[612] S. Vannucci,et al. Glucose Transporter Asymmetries in the Bovine Blood-Brain Barrier* , 2001, The Journal of Biological Chemistry.
[613] T. Kigawa,et al. Role of the ENTH domain in phosphatidylinositol-4,5-bisphosphate binding and endocytosis. , 2001, Science.
[614] W. A. Banks. Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity. , 2001, Current pharmaceutical design.
[615] D. Holtzman,et al. Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice. , 2001, Journal of Alzheimer's disease : JAD.
[616] D. Holtzman,et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. , 2000, The Journal of clinical investigation.
[617] B. Zlokovic,et al. beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. , 2000, American journal of physiology. Cell physiology.
[618] C. Morris,et al. Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation. , 2000, Brain : a journal of neurology.
[619] T. Noda,et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. , 2000, Molecular biology of the cell.
[620] B. Hyman,et al. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APPV717F transgenic mice , 2000, Acta Neuropathologica.
[621] Dong Wang,et al. Mutational analysis of GLUT1 (SLC2A1) in Glut‐1 Deficiency Syndrome , 2000, Human mutation.
[622] C. Redies,et al. N‐cadherin mediates pericytic‐endothelial interaction during brain angiogenesis in the chicken , 2000 .
[623] A. Fagan,et al. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model , 2000, Annals of neurology.
[624] H. Ueda,et al. Immunolocalization of dystrobrevin in the astrocytic endfeet and endothelial cells in the rat cerebellum , 2000, Neuroscience Letters.
[625] B. Zlokovic,et al. Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier. , 2000, Endocrinology.
[626] A. Fagan,et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[627] D. Galasko,et al. Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. , 2000, Biochemical and biophysical research communications.
[628] V. Ganapathy,et al. β-Lactam Antibiotics as Substrates for OCTN2, an Organic Cation/Carnitine Transporter* , 2000, The Journal of Biological Chemistry.
[629] F. Luscinskas,et al. Monocytes Induce Reversible Focal Changes in Vascular Endothelial Cadherin Complex during Transendothelial Migration under Flow , 2000, The Journal of cell biology.
[630] S. Paul,et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[631] B. Zlokovic,et al. Functional and structural properties of lipid-associated apolipoprotein J (clusterin). , 1999, The Biochemical journal.
[632] J. Viña,et al. Na+-dependent Glutamate Transporters (EAAT1, EAAT2, and EAAT3) of the Blood-Brain Barrier , 1999, The Journal of Biological Chemistry.
[633] G. Rosenberg,et al. Ischemic brain edema. , 1999, Progress in cardiovascular diseases.
[634] K. Willecke,et al. Characterization of the gap junction protein connexin37 in murine endothelium, respiratory epithelium, and after transfection in human HeLa cells. , 1998, European journal of cell biology.
[635] J. Wegiel,et al. Cell-Type-Specific Enhancement of Amyloid-β Deposition in a Novel Presenilin-1 Mutation (P117L) , 1998, Journal of neuropathology and experimental neurology.
[636] M Filippi,et al. Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.
[637] K. Blennow,et al. A population study on blood-brain barrier function in 85-year-olds , 1998, Neurology.
[638] J. Viña,et al. Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal. , 1998, American journal of physiology. Cell physiology.
[639] S. M. Sumi,et al. Amyloid angiopathy in a volga german family with Alzheimer's disease and a presenilin‐2 mutation (N141I) , 1998, Annals of neurology.
[640] C. Cass,et al. Recent advances in the molecular biology of nucleoside transporters of mammalian cells. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[641] G. Shah,et al. GLUT-1 Expression in the Cerebra of Patients with Alzheimer’s Disease , 1997, Neurobiology of Aging.
[642] Y. Ikejiri,et al. A novel missense mutation in the presenilin-1 gene in a familial Alzheimer's disease pedigree with abundant amyloid angiopathy , 1997, Neuroscience Letters.
[643] B R Johansson,et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.
[644] H. Mori,et al. Increased Aβ 42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene , 1997, Neuroscience Letters.
[645] R. Dempsey,et al. The biphasic opening of the blood–brain barrier in the cortex and hippocampus after traumatic brain injury in rats , 1997, Neuroscience Letters.
[646] W. Markesbery,et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.
[647] Nick C Fox,et al. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. , 1997, Brain : a journal of neurology.
[648] S. Scheff,et al. Evaluation of the temporal evolution of acute spinal cord injury. , 1997, Investigative radiology.
[649] E. Beyer,et al. Differential regulation of connexin43 and connexin37 in endothelial cells by cell density, growth, and TGF-beta1. , 1997, The American journal of physiology.
[650] W. Pardridge,et al. Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. , 1997, The Journal of clinical investigation.
[651] G. Schellenberg,et al. The Clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients , 1996, Annals of neurology.
[652] B. Stokes,et al. A Quantitative Spatial Analysis of the Blood–Spinal Cord Barrier I. Permeability Changes after Experimental Spinal Contusion Injury , 1996, Experimental Neurology.
[653] Kenneth S. Kosik,et al. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology , 1996, Nature Medicine.
[654] S. M. Sumi,et al. Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ42(43) , 1996 .
[655] G. Schellenberg,et al. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.
[656] E. Matsubara,et al. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[657] Katsuhide Ito,et al. Low intensity areas observed on T2-weighted magnetic resonance imaging of the cerebral cortex in various neurological diseases , 1995, Journal of the Neurological Sciences.
[658] J. Greenwood,et al. Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off. , 1995, Immunology.
[659] J. Connor,et al. Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions , 1995, Journal of neurochemistry.
[660] B. Duling,et al. Connexin 43 and connexin 40 gap junctional proteins are present in arteriolar smooth muscle and endothelium in vivo. , 1995, The American journal of physiology.
[661] A. Roses,et al. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. , 1994, The Journal of clinical investigation.
[662] W. Honer,et al. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease , 1994, Annals of neurology.
[663] K. Ohtomo,et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. , 1993, Radiology.
[664] F. Bianchi,et al. Laser nephelometric evaluation of albumin, IgG and α 2-macroglobulin: applications to the study of alterations of the blood-brain barrier , 1993, Journal of the Neurological Sciences.
[665] A. Roses,et al. Novel polymorphism in the A4 region of the amyloid precursor protein gene in a patient without Alzheimer's disease , 1993, Neurology.
[666] Q. Smith,et al. Identification of the Cationic Amino Acid Transporter (System y+) of the Rat Blood‐Brain Barrier , 1993, Journal of neurochemistry.
[667] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[668] J. Tajti,et al. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. , 1993, Archives of neurology.
[669] W. Pardridge,et al. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. , 1991, The Journal of pharmacology and experimental therapeutics.
[670] W. Pardridge,et al. Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[671] T. Ichimura,et al. Distribution of extracellular tracers in perivascular spaces of the rat brain , 1991, Brain Research.
[672] K. Blennow,et al. White‐matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors , 1991, Acta neurologica Scandinavica.
[673] J. Nikolić,et al. Serum and CSF immunological findings in ALS , 1991, Acta neurologica Scandinavica.
[674] H. Davson,et al. Kinetics of circulating vasopressin uptake by choroid plexus. , 1991, The American journal of physiology.
[675] E. Hertzberg,et al. On the organization of astrocytic gap junctions in rat brain as suggested by LM and EM immunohistochemistry of connexin43 expression , 1990, The Journal of comparative neurology.
[676] S. Appel,et al. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. , 1990, Archives of neurology.
[677] D. Troost,et al. Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis , 1990, Neuropathology and applied neurobiology.
[678] H. Davson,et al. Kinetics of arginine-vasopressin uptake at the blood-brain barrier. , 1990, Biochimica et biophysica acta.
[679] I Karlsson,et al. Blood‐brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors , 1990, Acta neurologica Scandinavica.
[680] O. H. Lowry,et al. Use of nonradioactive 2-deoxyglucose to study compartmentation of brain glucose metabolism and rapid regional changes in rate. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[681] R N Kalaria,et al. Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer Disease , 1989, Journal of neurochemistry.
[682] R. Cecchelli,et al. Low‐Density Lipoprotein Receptor on Endothelium of Brain Capillaries , 1989, Journal of neurochemistry.
[683] L. Noble,et al. Distribution and time course of protein extravasation in the rat spinal cord after contusive injury , 1989, Brain Research.
[684] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[685] B. Zlokovic,et al. Evidence for a lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier specificity and effects of glucagon. , 1985, Biochimica et biophysica acta.
[686] D. Begley,et al. Blood-brain barrier permeability to leucine-enkephalin,d-Alanine2-d-leucine5-enkephalin and their N-terminal amino acid (tyrosine) , 1985, Brain Research.
[687] O. R. Blaumanis,et al. Evidence for a ‘Paravascular’ fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space , 1985, Brain Research.
[688] W. Jefferies,et al. Transferrin receptor on endothelium of brain capillaries , 1984, Nature.
[689] R. Kascsak,et al. Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients , 1984, Journal of Neuroimmunology.
[690] M. Wiley,et al. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail--chick transplantation chimeras. , 1981, Developmental biology.
[691] H. Cserr,et al. Drainage of cerebral interstitial fluid into deep cervical lymph of the rabbit. , 1981, The American journal of physiology.
[692] M. Reivich,et al. THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.
[693] G. Hochwald,et al. The sink action of cerebrospinal fluid volume flow. Effect on brain water content. , 1976, Archives of neurology.
[694] H. Davson. Review lecture. The blood‐brain barrier. , 1976, The Journal of physiology.
[695] W H Oldendorf,et al. Amino acid assignment to one of three blood-brain barrier amino acid carriers. , 1976, The American journal of physiology.
[696] K. Theiler. The house mouse. Development and normal stages from fertilization to 4 weeks of age. , 1972 .
[697] Thomas S. Reese,et al. FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE , 1967, The Journal of cell biology.
[698] A. Sols,et al. The non-competitive inhibition of brain hexokinase by glucose-6-phosphate and related compounds. , 1954, The Journal of biological chemistry.